Company
Earlens
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
3
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$282M
12 Form D offerings, 2011 to 2025
Equity
$249M
Stock sold for cash
Debt and convertible notes
$33.9M
$33.9M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $8.0M raised of $10.0M sought, first sale Feb 19, 2025, 6 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Feb 19, 2025 | Equity | $8.0M | $10.0M | 6 | Rule 506(b) | Form D ↗Mar 3, 2025 |
| Apr 8, 2024 | Equity | $18.8M | $43.6M | 8 | Rule 506(b) | Form D ↗Apr 18, 2024 |
| Apr 8, 2022 | Convertible note | $6.0M | $30.0M | 4 | Rule 506(b)Agent: Carofin, LLC, Carolina Financial Securities, LLC | Form D ↗Apr 25, 2022 |
9 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Earlens Corp
- Headquarters
- Menlo Park, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1490171 ↗
Executives, directors and promoters
As listed on the latest Form D.
5 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
K182480 · Decided Jan 25, 2019 · 137 days after receipt
Device type: Tympanic Membrane Direct Contact Hearing Aid (PLK) · Otolaryngology (ENT)
K153634 · Decided Apr 6, 2016 · 110 days after receipt
Device type: Tympanic Membrane Direct Contact Hearing Aid (PLK) · Otolaryngology (ENT)
- EarLens Contact Hearing DeviceNew device typeDe Novo
DEN150002 · Decided Sep 29, 2015 · 270 days after receipt
Device type: Tympanic Membrane Direct Contact Hearing Aid (PLK) · Otolaryngology (ENT)
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT02470494 · 46 participants · Start Jun 2015 · Primary completion Jun 2016
Device: Sound amplification provided via the EarLens CHD · For: Hearing Loss, Sensorineural
Sites: La Jolla, California; Menlo Park, California; San Jose, California · 8 sites in all
NCT00582946 · 16 participants · Start May 2006 · Primary completion Dec 2009
Device: Hearing Aid · For: Hearing Impairment
Sites: Redwood City, California
NCT02042404 · 48 participants · Start Mar 2014 · Primary completion Jan 2015
Device: Sound amplification provided via EarLens System. · For: Hearing Impairment
Sites: Menlo Park, California; San Jose, California; Iowa City, Iowa
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.